Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV”

592 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 592 results

Early research (Phase 1)Study completedNCT05712460
What this trial is testing

Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Not applicableNot Yet RecruitingNCT07075029
What this trial is testing

RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China

Who this might be right for
Acute Respiratory Infections (ARIs)
Huashan Hospital 28,800
Testing effectiveness (Phase 2)WithdrawnNCT04267822
What this trial is testing

Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV

Who this might be right for
RSV InfectionStem Cell Transplant ComplicationsLower Resp Tract Infection
Pfizer
Not applicableUnknownNCT02519803
What this trial is testing

A Prospective Household Observational Cohort Study of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens Community Burden and Transmission Dynamics in South Africa

Who this might be right for
Infective Organism Causing Respiratory Diseaseand Meningitis
National Institute for Communicable Diseases, South Africa 4,500
Large-scale testing (Phase 3)Active Not RecruitingNCT05035212
What this trial is testing

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

Who this might be right for
Lower Respiratory Tract Illness
Pfizer 38,861
Not applicableLooking for participantsNCT06639386
What this trial is testing

Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

Who this might be right for
Vaccine HesitancyVaccine Refusal
Boston Medical Center 80
Early research (Phase 1)Study completedNCT03596801
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Ended earlyNCT02890381
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableNot Yet RecruitingNCT07643688
What this trial is testing

Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections

Who this might be right for
SARS CoV 2 InfectionRSV InfectionsInfluenza Infection
Fabiana Sherine Ganem dos Santos 150
Large-scale testing (Phase 3)Study completedNCT06593587
What this trial is testing

Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea

Who this might be right for
Respiratory Syncytial Virus
Pfizer 378
Testing effectiveness (Phase 2)Looking for participantsNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 184
Not applicableUnknownNCT05277298
What this trial is testing

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Who this might be right for
SARS-CoV-2 InfectionInfluenzaRespiratory Syncytial Virus (RSV)
National Institute for Communicable Diseases, South Africa 1,200
Large-scale testing (Phase 3)Study completedNCT04938830
What this trial is testing

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

Who this might be right for
RSV Infection
Merck Sharp & Dohme LLC 1,003
Not applicableLooking for participantsNCT07200206
What this trial is testing

A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea

Who this might be right for
Respiratory Syncytial Virus
Sanofi 3,000
Early research (Phase 1)UnknownNCT04909021
What this trial is testing

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

Who this might be right for
Respiratory Syncytial Virus (RSV)
Meissa Vaccines, Inc. 63
Early research (Phase 1)Study completedNCT02668367
What this trial is testing

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 36
Not applicableStudy completedNCT01754428
What this trial is testing

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences 2,432
Not applicableStudy completedNCT05622331
What this trial is testing

Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden

Who this might be right for
Respiratory Syncytial Virus (RSV)
Sanofi Pasteur, a Sanofi Company 1,100,000
Testing effectiveness (Phase 2)Study completedNCT02707523
What this trial is testing

Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

Who this might be right for
Respiratory Syncytial Virus
University of Alabama at Birmingham 48
Load More Results